Search company, investor...


Founded Year



Series B | Alive

Total Raised


Last Raised

$10M | 2 yrs ago

About LensGen

LensGen is developing Juvene, a modular, fluid-optic accommodating intraocular lens which is designed with the potential to permanently restore clear and continuous vision at all distances for patients with cataracts and presbyopia. The lens provides accommodation by mimicking the eye's natural accommodation process to change shape and adjust focus, like the autofocus of a camera. The lens is implanted using current surgical techniques used for traditional intraocular lenses.

Headquarters Location

6 Jenner Suite 230

Irvine, California, 92618,

United States


LensGen's Product Videos

Compete with LensGen?

Ensure that your company and products are accurately represented on our platform.

LensGen's Products & Differentiators


    Premium intraocular lens (IOL)

Expert Collections containing LensGen

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

LensGen is included in 2 Expert Collections, including Medical Devices.


Medical Devices

9,018 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.


Health IT

7,901 items

LensGen Patents

LensGen has filed 25 patents.

The 3 most popular patent topics include:

  • Eye surgery
  • Ophthalmology
  • Vision
patents chart

Application Date

Grant Date


Related Topics




Ophthalmology, Vision, Eye surgery, Corrective lenses, Diseases of the eye and adnexa


Application Date


Grant Date



Related Topics

Ophthalmology, Vision, Eye surgery, Corrective lenses, Diseases of the eye and adnexa



LensGen Frequently Asked Questions (FAQ)

  • When was LensGen founded?

    LensGen was founded in 2011.

  • Where is LensGen's headquarters?

    LensGen's headquarters is located at 6 Jenner, Irvine.

  • What is LensGen's latest funding round?

    LensGen's latest funding round is Series B.

  • How much did LensGen raise?

    LensGen raised a total of $41.15M.

  • Who are the investors of LensGen?

    Investors of LensGen include HOYA, Relativity Healthcare Partners, Rahul Harkawat, Amir Banifatemi, K5 Ventures and 3 more.

  • Who are LensGen's competitors?

    Competitors of LensGen include Alcon.

  • What products does LensGen offer?

    LensGen's products include Juvene.

Compare LensGen to Competitors


Ophthorobotics provides a solution for the delivery of intravitreal injections to treat chronic ocular diseases.

GlaucoT Logo

GlaucoT is a healthcare and biotechnology company that develops a neuroprotective glaucoma treatment with non-drug and non-invasive techniques. The company was founded in 2019 and is based in Istanbul, Turkey.


Alcon (SIX/NYSE: ALC) develops, manufactures, and markets pharmaceuticals, surgical equipment, and devices. It provides contact lenses and other vision care products. Alcon also helps people to get rid of certain diseases, such as presbyopia, and dry eye, and also helps people who are blind from cataracts. The company was founded in 1945 and is based in Fort Worth, Texas.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.